Chen, K., Cambi, F., & Kozai, T.D.Y. (2023). Pro-myelinating Clemastine administration improves recording performance of chronically implanted microelectrodes and nearby neuronal health. bioRxiv, 4(02-10), 2023.01.31.526463.Cold Spring Harbor Laboratory. doi: 10.1101/2023.01.31.526463.
Klimas, A., Gallagher, B.R., Wijesekara, P., Fekir, S., DiBernardo, E.F., Cheng, Z., Stolz, D.B., Cambi, F., Watkins, S.C., Brody, S.L., Horani, A., Barth, A.L., Moore, C.I., Ren, X., & Zhao, Y. (2023). Magnify is a universal molecular anchoring strategy for expansion microscopy. Nat Biotechnol, 41(6), 858-869.Springer Nature. doi: 10.1038/s41587-022-01546-1.
Song, S., Hasan, M.N., Yu, L., Paruchuri, S.S., Bielanin, J.P., Metwally, S., Oft, H.C.M., Fischer, S.G., Fiesler, V.M., Sen, T., Gupta, R.K., Foley, L.M., Hitchens, T.K., Dixon, C.E., Cambi, F., Sen, N., & Sun, D. (2022). Microglial-oligodendrocyte interactions in myelination and neurological function recovery after traumatic brain injury. J Neuroinflammation, 19(1), 246.Springer Nature. doi: 10.1186/s12974-022-02608-6.
Dubaniewicz, M., Eles, J.R., Lam, S., Song, S., Cambi, F., Sun, D., Wellman, S.M., & Kozai, T.D.Y. (2021). Inhibition of Na+/H+exchanger modulates microglial activation and scar formation following microelectrode implantation. J Neural Eng, 18(4), 045001.IOP Publishing. doi: 10.1088/1741-2552/abe8f1.
Zhang, S., Wang, Y., Zhu, X., Song, L., Zhan, X., Ma, E., McDonough, J., Fu, H., Cambi, F., Grinspan, J., & Guo, F. (2021). The Wnt Effector TCF7l2 Promotes Oligodendroglial Differentiation by Repressing Autocrine BMP4-Mediated Signaling. J Neurosci, 41(8), 1650-1664.Society for Neuroscience. doi: 10.1523/JNEUROSCI.2386-20.2021.
Guzman, K.M., Brink, L.E., Rodriguez-Bey, G., Bodnar, R.J., Kuang, L., Xing, B., Sullivan, M., Park, H.J., Koppes, E., Zhu, H., Padiath, Q., & Cambi, F. (2020). Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation. Glia, 68(10), 2040-2056.Wiley. doi: 10.1002/glia.23825.
Su, X.W., Palka, S.V., Rao, R.R., Chen, F.S., Brackney, C.R., & Cambi, F. (2020). SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia. Muscle Nerve, 62(2), E48-E49.Wiley. doi: 10.1002/mus.26988.
Wellman, S.M., Guzman, K., Stieger, K.C., Brink, L.E., Sridhar, S., Dubaniewicz, M.T., Li, L., Cambi, F., & Kozai, T.D.Y. (2020). Cuprizone-induced oligodendrocyte loss and demyelination impairs recording performance of chronically implanted neural interfaces. Biomaterials, 239, 119842.Elsevier. doi: 10.1016/j.biomaterials.2020.119842.
Espay, A.J., Vizcarra, J.A., Marsili, L., Lang, A.E., Simon, D.K., Merola, A., Josephs, K.A., Fasano, A., Morgante, F., Savica, R., Greenamyre, J.T., Cambi, F., Yamasaki, T.R., Tanner, C.M., Gan-Or, Z., Litvan, I., Mata, I.F., Zabetian, C.P., Brundin, P., Fernandez, H.H., Standaert, D.G., Kauffman, M.A., Schwarzschild, M.A., Sardi, S.P., Sherer, T., Perry, G., & Leverenz, J.B. (2019). Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology, 92(7), 329-337.Wolters Kluwer. doi: 10.1212/WNL.0000000000006926.
Wellman, S.M., Cambi, F., & Kozai, T.D. (2018). The role of oligodendrocytes and their progenitors on neural interface technology: A novel perspective on tissue regeneration and repair. Biomaterials, 183, 200-217.Elsevier. doi: 10.1016/j.biomaterials.2018.08.046.
Xing, B., Brink, L.E., Maers, K., Sullivan, M.L., Bodnar, R.J., Stolz, D.B., & Cambi, F. (2018). Conditional depletion of GSK3b protects oligodendrocytes from apoptosis and lessens demyelination in the acute cuprizone model. Glia, 66(9), 1999-2012.Wiley. doi: 10.1002/glia.23453.
Leehey, M., Luo, S., Sharma, S., Wills, A.M.A., Bainbridge, J.L., Wong, P.S., Simon, D.K., Schneider, J., Zhang, Y., Pérez, A., Dhall, R., Christine, C.W., Singer, C., Cambi, F., & Boyd, J.T. (2017). Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores. Neurology, 89(17), 1789-1794.Wolters Kluwer. doi: 10.1212/WNL.0000000000004572.
Kapeli, K., Pratt, G.A., Vu, A.Q., Hutt, K.R., Martinez, F.J., Sundararaman, B., Batra, R., Freese, P., Lambert, N.J., Huelga, S.C., Chun, S.J., Liang, T.Y., Chang, J., Donohue, J.P., Shiue, L., Zhang, J., Zhu, H., Cambi, F., Kasarskis, E., Hoon, S., Ares, M., Burge, C.B., Ravits, J., Rigo, F., & Yeo, G.W. (2016). Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat Commun, 7(1), 12143.Springer Nature. doi: 10.1038/ncomms12143.
NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators. (2015). Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. Lancet Neurol, 14(8), 795-803.Elsevier. doi: 10.1016/S1474-4422(15)00144-1.
Schneider, J.S., Cambi, F., Gollomp, S.M., Kuwabara, H., Brašić, J.R., Leiby, B., Sendek, S., & Wong, D.F. (2015). GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding. J Neurol Sci, 356(1-2), 118-123.Elsevier. doi: 10.1016/j.jns.2015.06.028.
Elm, J.J., & NINDS NET-PD Investigators. (2012). Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. Mov Disord, 27(12), 1513-1521.Wiley. doi: 10.1002/mds.25175.
Goldman, S.M., Quinlan, P.J., Ross, G.W., Marras, C., Meng, C., Bhudhikanok, G.S., Comyns, K., Korell, M., Chade, A.R., Kasten, M., Priestley, B., Chou, K.L., Fernandez, H.H., Cambi, F., Langston, J.W., & Tanner, C.M. (2012). Solvent exposures and Parkinson disease risk in twins. Ann Neurol, 71(6), 776-784.Wiley. doi: 10.1002/ana.22629.
Magen, S., Magnani, R., Haziza, S., Hershkovitz, E., Houtz, R., Cambi, F., & Parvari, R. (2012). Human calmodulin methyltransferase: expression, activity on calmodulin, and Hsp90 dependence. In Strack, S. (Ed.). PLoS One, 7(12), e52425.Public Library of Science (PLoS). doi: 10.1371/journal.pone.0052425.
Wang, E., & Cambi, F. (2012). MicroRNA expression in mouse oligodendrocytes and regulation of proteolipid protein gene expression. J Neurosci Res, 90(9), 1701-1712.Wiley. doi: 10.1002/jnr.23055.
Wang, E., Aslanzadeh, V., Papa, F., Zhu, H., de la Grange, P., & Cambi, F. (2012). Global profiling of alternative splicing events and gene expression regulated by hnRNPH/F. In Xing, Y. (Ed.). PLoS One, 7(12), e51266.Public Library of Science (PLoS). doi: 10.1371/journal.pone.0051266.
Zhu, H., Zhao, L., Wang, E., Dimova, N., Liu, G., Feng, Y., & Cambi, F. (2012). The QKI-PLP pathway controls SIRT2 abundance in CNS myelin. Glia, 60(1), 69-82.Wiley. doi: 10.1002/glia.21248.
Tanner, C.M., Kamel, F., Ross, G.W., Hoppin, J.A., Goldman, S.M., Korell, M., Marras, C., Bhudhikanok, G.S., Kasten, M., Chade, A.R., Comyns, K., Richards, M.B., Meng, C., Priestley, B., Fernandez, H.H., Cambi, F., Umbach, D.M., Blair, A., Sandler, D.P., & Langston, J.W. (2011). Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect, 119(6), 866-872.Environmental Health Perspectives. doi: 10.1289/ehp.1002839.
Wang, E., Mueller, W.F., Hertel, K.J., & Cambi, F. (2011). G Run-mediated recognition of proteolipid protein and DM20 5' splice sites by U1 small nuclear RNA is regulated by context and proximity to the splice site. J Biol Chem, 286(6), 4059-4071.Elsevier. doi: 10.1074/jbc.M110.199927.
Bargagna-Mohan, P., Paranthan, R.R., Hamza, A., Dimova, N., Trucchi, B., Srinivasan, C., Elliott, G.I., Zhan, C.G., Lau, D.L., Zhu, H., Kasahara, K., Inagaki, M., Cambi, F., & Mohan, R. (2010). Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis. J Biol Chem, 285(10), 7657-7669.Elsevier. doi: 10.1074/jbc.M109.093765.
Schneider, J.S., Sendek, S., Daskalakis, C., & Cambi, F. (2010). GM1 ganglioside in Parkinson's disease: Results of a five year open study. J Neurol Sci, 292(1-2), 45-51.Elsevier. doi: 10.1016/j.jns.2010.02.009.
Wang, E., & Cambi, F. (2009). Heterogeneous nuclear ribonucleoproteins H and F regulate the proteolipid protein/DM20 ratio by recruiting U1 small nuclear ribonucleoprotein through a complex array of G runs. J Biol Chem, 284(17), 11194-11204.Elsevier. doi: 10.1074/jbc.M809373200.
DeStefano, A.L., Latourelle, J., Lew, M.F., Suchowersky, O., Klein, C., Golbe, L.I., Mark, M.H., Growdon, J.H., Wooten, G.F., Watts, R., Guttman, M., Racette, B.A., Perlmutter, J.S., Marlor, L., Shill, H.A., Singer, C., Goldwurm, S., Pezzoli, G., Saint-Hilaire, M.H., Hendricks, A.E., Gower, A., Williamson, S., Nagle, M.W., Wilk, J.B., Massood, T., Huskey, K.W., Baker, K.B., Itin, I., Litvan, I., Nicholson, G., Corbett, A., Nance, M., Drasby, E., Isaacson, S., Burn, D.J., Chinnery, P.F., Pramstaller, P.P., Al-Hinti, J., Moller, A.T., Ostergaard, K., Sherman, S.J., Roxburgh, R., Snow, B., Slevin, J.T., Cambi, F., Gusella, J.F., & Myers, R.H. (2008). Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Hum Genet, 124(1), 95-99.Springer Nature. doi: 10.1007/s00439-008-0526-4.
Latourelle, J.C., Sun, M., Lew, M.F., Suchowersky, O., Klein, C., Golbe, L.I., Mark, M.H., Growdon, J.H., Wooten, G.F., Watts, R.L., Guttman, M., Racette, B.A., Perlmutter, J.S., Ahmed, A., Shill, H.A., Singer, C., Goldwurm, S., Pezzoli, G., Zini, M., Saint-Hilaire, M.H., Hendricks, A.E., Williamson, S., Nagle, M.W., Wilk, J.B., Massood, T., Huskey, K.W., Laramie, J.M., DeStefano, A.L., Baker, K.B., Itin, I., Litvan, I., Nicholson, G., Corbett, A., Nance, M., Drasby, E., Isaacson, S., Burn, D.J., Chinnery, P.F., Pramstaller, P.P., Al-hinti, J., Moller, A.T., Ostergaard, K., Sherman, S.J., Roxburgh, R., Snow, B., Slevin, J.T., Cambi, F., Gusella, J.F., & Myers, R.H. (2008). The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med, 6(1), 32.Springer Nature. doi: 10.1186/1741-7015-6-32.
McNicoll, C.F., Latourelle, J.C., MacDonald, M.E., Lew, M.F., Suchowersky, O., Klein, C., Golbe, L.I., Mark, M.H., Growdon, J.H., Wooten, G.F., Watts, R.L., Guttman, M., Racette, B.A., Perlmutter, J.S., Ahmed, A., Shill, H.A., Singer, C., Saint-Hilaire, M.H., Massood, T., Huskey, K.W., DeStefano, A.L., Gillis, T., Mysore, J., Goldwurm, S., Pezzoli, G., Baker, K.B., Itin, I., Litvan, I., Nicholson, G., Corbett, A., Nance, M., Drasby, E., Isaacson, S., Burn, D.J., Chinnery, P.F., Pramstaller, P.P., Al-Hinti, J., Moller, A.T., Ostergaard, K., Sherman, S.J., Roxburgh, R., Snow, B., Slevin, J.T., Cambi, F., Gusella, J.F., & Myers, R.H. (2008). Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord, 23(11), 1596-1601.Wiley. doi: 10.1002/mds.22186.
Tobin, J.E., Latourelle, J.C., Lew, M.F., Klein, C., Suchowersky, O., Shill, H.A., Golbe, L.I., Mark, M.H., Growdon, J.H., Wooten, G.F., Racette, B.A., Perlmutter, J.S., Watts, R., Guttman, M., Baker, K.B., Goldwurm, S., Pezzoli, G., Singer, C., Saint-Hilaire, M.H., Hendricks, A.E., Williamson, S., Nagle, M.W., Wilk, J.B., Massood, T., Laramie, J.M., DeStefano, A.L., Litvan, I., Nicholson, G., Corbett, A., Isaacson, S., Burn, D.J., Chinnery, P.F., Pramstaller, P.P., Sherman, S., Al-hinti, J., Drasby, E., Nance, M., Moller, A.T., Ostergaard, K., Roxburgh, R., Snow, B., Slevin, J.T., Cambi, F., Gusella, J.F., & Myers, R.H. (2008). Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology, 71(1), 28-34.Wolters Kluwer. doi: 10.1212/01.wnl.0000304051.01650.23.
Wang, E., Dimova, N., Sperle, K., Huang, Z., Lock, L., McCulloch, M.C., Edgar, J.M., Hobson, G.M., & Cambi, F. (2008). Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability. Exp Neurol, 214(2), 322-330.Elsevier. doi: 10.1016/j.expneurol.2008.09.001.
Squillaro, T., Cambi, F., Ciacci, G., Rossi, S., Ulivelli, M., Malandrini, A., Mencarelli, M.A., Mari, F., Renieri, A., & Ariani, F. (2007). Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease. J Hum Genet, 52(3), 201-204.Springer Nature. doi: 10.1007/s10038-006-0105-2.
Wang, E., Dimova, N., & Cambi, F. (2007). PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes. Nucleic Acids Res, 35(12), 4164-4178.Oxford University Press (OUP). doi: 10.1093/nar/gkm387.
Hobson, G.M., Huang, Z., Sperle, K., Sistermans, E., Rogan, P.K., Garbern, J.Y., Kolodny, E., Naidu, S., & Cambi, F. (2006). Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes. Hum Mutat, 27(1), 69-77.Hindawi. doi: 10.1002/humu.20276.
Sabet, A., Li, J., Ghandour, K., Pu, Q., Wu, X., Kamholz, J., Shy, M.E., & Cambi, F. (2006). Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B. Neurology, 67(7), 1141-1146.Wolters Kluwer. doi: 10.1212/01.wnl.0000238499.37764.b1.
Wang, E., Huang, Z., Hobson, G.M., Dimova, N., Sperle, K., McCullough, A., & Cambi, F. (2006). PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer. J Cell Biochem, 97(5), 999-1016.Wiley. doi: 10.1002/jcb.20692.
Wilk, J.B., Tobin, J.E., Suchowersky, O., Shill, H.A., Klein, C., Wooten, G.F., Lew, M.F., Mark, M.H., Guttman, M., Watts, R.L., Singer, C., Growdon, J.H., Latourelle, J.C., Saint-Hilaire, M.H., DeStefano, A.L., Prakash, R., Williamson, S., Berg, C.J., Sun, M., Goldwurm, S., Pezzoli, G., Racette, B.A., Perlmutter, J.S., Parsian, A., Baker, K.B., Giroux, M.L., Litvan, I., Pramstaller, P.P., Nicholson, G., Burn, D.J., Chinnery, P.F., Vieregge, P., Slevin, J.T., Cambi, F., MacDonald, M.E., Gusella, J.F., Myers, R.H., & Golbe, L.I. (2006). Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology, 67(12), 2206-2210.Wolters Kluwer. doi: 10.1212/01.wnl.0000249149.22407.d1.
Mari, F., Kilstrup-Nielsen, C., Cambi, F., Speciale, C., Mencarelli, M.A., & Renieri, A. (2005). Genetics and mechanisms of disease in Rett syndrome. Drug Discovery Today Disease Mechanisms, 2(4), 419-425.Elsevier. doi: 10.1016/j.ddmec.2005.11.001.
Garbern, J., Shy, M., Krajewski, K., Kamholz, J., Hobson, G., & Cambi, F. (2001). Evidence for neuroaxonal injury in patients with proteolipid gene mutations. Neurology, 57(10), 1938-1939.Wolters Kluwer. doi: 10.1212/wnl.57.10.1938-a.
Mars, T., Yu, K.J., Tang, X.M., Miranda, A.F., Grubic, Z., Cambi, F., & King, M.P. (2001). Differentiation of glial cells and motor neurons during the formation of neuromuscular junctions in cocultures of rat spinal cord explant and human muscle. J Comp Neurol, 438(2), 239-251.Wiley. doi: 10.1002/cne.1312.
Awatramani, R., Beesley, J., Yang, H., Jiang, H., Cambi, F., Grinspan, J., Garbern, J., & Kamholz, J. (2000). Gtx, an oligondendrocyte-specific homeodomain protein, has repressor activity. Journal of Neuroscience Research, 61(4), 376-387. doi: 10.1002/1097-4547(20000815)61:4<376::aid-jnr4>3.0.co;2-%23.
Awatramani, R., Beesley, J., Yang, H., Jiang, H., Cambi, F., Grinspan, J., Garbern, J., & Kamholz, J. (2000). Gtx, an oligodendrocyte-specific homeodomain protein, has repressor activity. J Neurosci Res, 61(4), 376-387.Wiley. doi: 10.1002/1097-4547(20000815)61:4<376::AID-JNR4>3.0.CO;2-#.
Hentati, A., Deng, H.X., Zhai, H., Chen, W., Yang, Y., Hung, W.Y., Azim, A.C., Bohlega, S., Tandan, R., Warner, C., Laing, N.G., Cambi, F., Mitsumoto, H., Roos, R.P., Boustany, R.M., Ben Hamida, M., Hentati, F., & Siddique, T. (2000). Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. Neurology, 55(9), 1388-1390.Wolters Kluwer. doi: 10.1212/wnl.55.9.1388.
Tang, X.M., Beesley, J.S., Grinspan, J.B., Seth, P., Kamholz, J., & Cambi, F. (2000). Cell cycle arrest induced by ectopic expression of p27 is not sufficient to promote oligodendrocyte differentiation. Journal of Cellular Biochemistry, 76(2), 270-279. doi: 10.1002/(SICI)1097-4644(20000201)76:2<270::AID-JCB10>3.0.CO;2-6.
Garbern, J., Cambi, F., Shy, M., & Kamholz, J. (1999). The molecular pathogenesis of Pelizaeus-Merzbacher disease. Arch Neurol, 56(10), 1210-1214.American Medical Association (AMA). doi: 10.1001/archneur.56.10.1210.
Garbern, J.Y., Cambi, F., Lewis, R., Shy, M., Sima, A., Kraft, G., Vallat, J.M., Bosch, E.P., Hodes, M.E., Dlouhy, S., Raskind, W., Bird, T., Macklin, W., & Kamholz, J. (1999). Peripheral neuropathy caused by proteolipid protein gene mutations. Ann N Y Acad Sci, 883(1), 351-365.Wiley. doi: 10.1111/j.1749-6632.1999.tb08597.x.
Tang, X.M., Beesley, J.S., Grinspan, J.B., Seth, P., Kamholz, J., & Cambi, F. (1999). Cell cycle arrest induced by ectopic expression of p27 is not sufficient to promote oligodendrocyte differentiation. J Cell Biochem, 76(2), 270-279.Wiley. doi: 10.1002/(sici)1097-4644(20000201)76:2<270::aid-jcb10>3.0.co;2-6.
Tang, X.M., Strocchi, P., & Cambi, F. (1998). Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes. J Cell Biochem, 68(1), 128-137.Wiley. doi: 10.1002/(sici)1097-4644(19980101)68:1<128::aid-jcb13>3.0.co;2-d.
Tang, X.M., Strocchi, P., & Cambi, F. (1998). Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes. Journal of Cellular Biochemistry, 68(1), 128-137. doi: 10.1002/(SICI)1097-4644(19980101)68:1<128::AID-JCB13>3.0.CO;2-D.
Berghella, V., Steele, D., Spector, T., Cambi, F., & Johnson, A. (1997). Successful pregnancy in a neurologically impaired woman with Wilson's disease. Am J Obstet Gynecol, 176(3), 712-714.Elsevier. doi: 10.1016/s0002-9378(97)70577-5.
Garbern, J.Y., Cambi, F., Tang, X.M., Sima, A.A., Vallat, J.M., Bosch, E.P., Lewis, R., Shy, M., Sohi, J., Kraft, G., Chen, K.L., Joshi, I., Leonard, D.G., Johnson, W., Raskind, W., Dlouhy, S.R., Pratt, V., Hodes, M.E., Bird, T., & Kamholz, J. (1997). Proteolipid protein is necessary in peripheral as well as central myelin. Neuron, 19(1), 205-218.Elsevier. doi: 10.1016/s0896-6273(00)80360-8.
Cambi, F., Tang, X.M., Cordray, P., Fain, P.R., Keppen, L.D., & Barker, D.F. (1996). Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia. Neurology, 46(4), 1112-1117.Wolters Kluwer. doi: 10.1212/wnl.46.4.1112.
Fink, J.K., HeimanPatterson, T., Bird, T., Cambi, F., Dube, M.P., Figlewicz, D.A.Fink, J.K., Haines, J.L., HeimanPatterson, T., Hentati, A., PericakVance, M.A., Raskind, W., Rouleau, G.A., & Siddique, T. (1996). Hereditary spastic paraplegia: Advances in genetic research. NEUROLOGY, 46(6), 1507-1514.Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/WNL.46.6.1507.
Fink, J.K., Heiman-Patterson, T., Bird, T., Cambi, F., Dubé, M.P., Figlewicz, D.A.Fink, J.K., Haines, J.L., Heiman-Patterson, T., Hentati, A., Pericak-Vance, M.A., Raskind, W., Rouleau, G.A., & Siddique, T. (1996). Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology, 46(6), 1507-1514.Wolters Kluwer. doi: 10.1212/wnl.46.6.1507.
Cambi, F., Tartaglino, L., Lublin, F., & McCarren, D. (1995). X-linked pure familial spastic paraparesis. Characterization of a large kindred with magnetic resonance imaging studies. Arch Neurol, 52(7), 665-669.American Medical Association (AMA). doi: 10.1001/archneur.1995.00540310035013.
Strocchi, P., Tang, X.M., & Cambi, F. (1995). Molecular diagnosis of transthyretin Met30 mutation in an Italian family with familial amyloidotic polyneuropathy. FEBS Lett, 359(2-3), 203-205.Wiley. doi: 10.1016/0014-5793(95)00046-c.
Hasan, M.N., Song, S., Paruchuri, S.S., Bielanin, J.P., Metwally, S., Sen, T., Gupta, R.K., Dixon, E., Cambi, F., Sen, N., & Sun, D. (2022). NA plus /H plus EXCHANGER IN INFLAMMATORY ACTIVATION OF MICROGLIA/MYELOID CELLS AND TRAUMATIC BRAIN INJURY OUTCOMES. In JOURNAL OF NEUROTRAUMA, 39(11-12), (pp. A29-A30).
Paruchuri, S.S., Song, S., Hasan, N., Bielanin, J.P., Metwally, S., Sen, T., Gupta, R.K., Dixon, C.E., Cambi, F., Sen, N., & Sun, D. (2022). SODIUM-HYDROGEN EXCHANGER (NHE1) AS A THERAPEUTIC TARGET FOR TRAUMATIC BRAIN INJURY. In JOURNAL OF NEUROTRAUMA, 39(11-12), (p. A63).
Palka, S., Su, X., & Cambi, F. (2021). SARS-CoV-2 Associated Guillain-Barre Syndrome with Dysautonomia. In NEUROLOGY, 96(15).
Song, S., Yu, L., Sen, T., Hasan, N., Gupta, R.K., Maers, K., Li, E., Cambi, F., Sen, N., & Sun, D. (2021). ROLES OF MICROGLIAL NA/H EXCHANGER IN WHITE MATTER DAMAGE AND NEUROLOGICAL DYSFUNCTION AFTER TRAUMATIC BRAIN INJURY. In JOURNAL OF NEUROTRAUMA, 38(14), (pp. A104-A105).
Song, S., Gupta, R., Yu, L., Maers, K., Li, E., Cambi, F., Sen, N., & Sun, D. (2019). RESTORATIVE MICROGLIA-OLIGODENDROCYTE INTERACTIONS IN POST-TBI REMYELINATION. In JOURNAL OF NEUROTRAUMA, 36(13), (p. A127).
Spears, C.C., Soneji, D., & Cambi, F. (2017). Fatal VZV Myelitis In Association With Chronic Corticosteroid and Mycophenolate Mofetil Therapy. In NEUROLOGY, 88.
Schneider, J.S., Sendek, S., Gollomp, S.M., Colcher, A., Cambi, F., & Du, W. (2011). A delayed start trial of GM1 ganglioside in Parkinson's disease. In MOVEMENT DISORDERS, 26, (p. S139).
Tanner, C.M., Kamel, F., Ross, G.W., Hoppin, J.A., Goldman, S.M., Korell, M., Marras, C., Bhudhikanok, G.S., Kasten, M., Chade, A., Comyns, K., Meng, C., Priestley, B., Fernandez, H.H., Cambi, F., Umbach, D.M., Blair, A., Sandler, D.P., & Langston, J.W. (2010). Rotenone, Paraquat and Parkinson's Disease (PD). In ANNALS OF NEUROLOGY, 68(4), (p. S17).
Wang, E., Dimova, N., Sperle, K., Lock, L., Hobson, G., & Cambi, F. (2008). Deletion of an intronic splicing enhancer impairs PLP1 splicing and myelin stability in vivo. In ANNALS OF NEUROLOGY, 64, (p. S35).
Cambi, F., Sperle, K., Huang, Z., Garbern, J., Rogan, P., & Hobson, G. (2006). Is PLP necessary for brain development and function? 'the human perspective'. In JOURNAL OF NEUROCHEMISTRY, 96, (p. 12).
Cambi, F., Hodes, M.E., Barker, D.F., Parrott, J., & Dlouhy, S.R. (2001). The same mutation in exon 5 of the proteolipid protein gene causes Pelizaeus-Merzbacher disease in one kindred and pure X-linked spastic paraplegia in an apparently unrelated family with a similar haplotype. In NEUROLOGY, 56(8), (p. A134).
Hobson, G.M., Huang, Z., MacCullough, A., Marks, H.G., Stabley, D., Sperle, K., & Cambi, F. (2001). Abnormal processing of proteolipid protein pre-mRNA is associated with an unusual Pelizaeus-Merzbacher disease. In AMERICAN JOURNAL OF HUMAN GENETICS, 69(4), (p. 598).
Huang, Z., & Cambi, F. (2001). Lineage progression of rat oligodendrocyte progenitor cells ectopically expressing p21-cip in vitro. In MOLECULAR BIOLOGY OF THE CELL, 12, (p. 10A).
Huang, Z., Tang, X.M., & Cambi, F. (2000). Early G1 cell cycle molecules and oligodendrocyte differentiation. In MOLECULAR BIOLOGY OF THE CELL, 11, (p. 451A).
Mars, T., King, M.P., Cambi, F., Miranda, A.F., & Grubic, Z. (2000). Agrin-specific antibodies reduce the final number of contracting units in innervated cultures of human muscle but do not abolish early contractions. In EUROPEAN JOURNAL OF NEUROSCIENCE, 12, (p. 281).
Cambi, F., Garbern, J., Shy, M., & Kamholz, J. (1999). X-linked spasticity syndromes caused by mutations in the PLP gene. In JOURNAL OF NEUROCHEMISTRY, 72, (p. S17).
Ghiani, C.A., Tang, X.M., Cambi, F., & Gallo, V. (1999). Expression and regulation of cyclin dependent kinase 5 in the oligodendrocyte lineage. In MOLECULAR BIOLOGY OF THE CELL, 10, (p. 433A).
Tang, X.M., Beesley, J., Grinspan, J., Seth, P., Kamholz, J., & Cambi, F. (1998). Cell cycle arrest induced by p27 is not sufficient to promote oligodendrocyte differentiation. In MOLECULAR BIOLOGY OF THE CELL, 9, (p. 240A).
Garbern, J.Y., Cambi, F., Lewis, R., Shy, M.E., Hodes, M.E., Dlouhy, S., Pratt, V., Sima, A., Bird, T., & Kamholz, J. (1997). Proteolipid protein (PLP) expression is critical for PNS as well as CNS myelination: Molecular and pathological characterization of a family with a novel PLP mutation. In NEUROLOGY, 48(3), (p. 6093).
Cambi, F., Tang, X.M., & Saitta, S. (1996). CDKs expression during oligodendrocytes differentiation. In MOLECULAR BIOLOGY OF THE CELL, 7, (p. 2125).
CAMBI, F., TANG, X.M., CORDRAY, P., FAIN, P.R., KEPPEN, L., & BARKER, D. (1995). LINKAGE OF PURE X-LINKED SPASTIC PARAPLEGIA TO XQ22 IN 2 PEDIGREES. In NEUROLOGY, 45(4), (pp. A439-A440).